Key result
Phenylephrine BP stabilization cuts cerebral vasomotion power ~94%, showing independence from neural activity.
Why the study?
Vasomotion may serve as a biomarker and therapeutic target for neurodegenerative diseases, but its origins, structure across brain vasculature, and correlation with neural activity remain unclear.
Absolute Event Rate: 326% vs 5731%
p-value: p=<0.001
Cerebral vasomotion is driven by the arterial tree and associated with low tissue oxygen, independent of spontaneous neural activity.
No takes yet. Share an insight, caveat, or question.
Challenges neurogenic models of cerebral vasomotion in animals; leaves open translation to human physiology.
Wang et al. (2025) studied Healthy (anaesthetised animal model) (n=18). Phenylephrine infusion vs. Pre-phenylephrine baseline (low blood pressure) was evaluated on Power of vasomotion (Hbt) in the whisker region artery (p=<0.001). Phenylephrine-induced blood pressure stabilization significantly reduced the median power of cerebral vasomotion from 5731 to 326, demonstrating that vasomotion is independent of spontaneous neural activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: